Health Care & Life Sciences » Biotechnology | Akari Therapeutics PLC

Akari Therapeutics PLC ADR | Cash Flow


No data

About Akari Therapeutics

View Profile
Address
75/76 Wimpole Street
London London & South East W1G 9RT
United Kingdom
Employees -
Website http://akaritx.com
Updated 07/08/2019
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Coversin, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.